Status:
COMPLETED
Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
The Cleveland Clinic
Centocor, Inc.
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study evaluated differences between men and women in the presentation, management and outcome of heart attacks within the GUSTO V study.
Detailed Description
The Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO) V trial examined a large, contemporary cohort of women and men with ST elevation myocardial infarction (STEMI...
Eligibility Criteria
Inclusion
- inclusion into GUSTO V
Exclusion
- lack of availability of data (database study)
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
October 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00245648
Start Date
June 1 2001
End Date
October 1 2007
Last Update
October 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU School of Medicine
New York, New York, United States, 10016